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Background: Cilia are essential organelles in multiple organ systems, including the kidney where they serve as
important regulators of renal homeostasis. Renal nephron cilia emanate from the apical membrane of epithelia,
extending into the lumen where they function in flow-sensing and ligand-dependent signaling cascades. Ciliary
dysfunction underlies renal cyst formation that is in part caused by deregulation of planar cell polarity and
canonical Wnt signaling. Renal cancer pathologies occur sporadically or in heritable syndromes caused by germline
mutations in tumor suppressor genes including VHL. Importantly, Von Hippel-Lindau (VHL) patients frequently
develop complex renal cysts that can be considered a premalignant stage. One of the well-characterized molecular
functions of VHL is its requirement for the maintenance of cilia. In this study, tissue from 110 renal cancer patients
who underwent nephrectomy was analyzed to determine if lower ciliary frequency is a common hallmark of renal
tumorigenesis by comparing cilia frequencies in both tumor and adjacent parenchymal tissue biopsies from the
same kidney.
Methods: We stained sections of human renal material using markers for cilia. Preliminary staining was performed
using an immunofluorescent approach and a combination of acetylated-α-tubulin and pericentrin antibodies and
DAPI. After validation of an alternative, higher throughput approach using acetylated-α-tubulin
immunohistochemistry, we continued to manually quantify cilia in all tissues. Nuclei were separately counted in an
automated fashion in order to determine ciliary frequencies. Similar staining and scoring for Ki67 positive cells was
performed to exclude that proliferation obscures cilia formation potential.
Results: Samples from renal cell carcinoma patients deposited in our hospital tissue bank were previously used to
compose a tissue microarray containing three cores of both tumor and parenchymal tissue per patient. Cilia
frequencies in a total of eighty-nine clear cell, eight papillary, five chromophobe renal cell carcinomas, two
sarcomatoid renal tumors and six oncocytomas were determined. A marked decrease of primary cilia across renal
cell carcinoma subtypes was observed compared to adjacent nontumorigenic tissue.
Conclusions: Our study shows that cilia are predominantly lost in renal cell carcinomas compared to tissue of the
tumor parenchyma. These results suggest that ciliary loss is common in renal tumorigenesis, possibly participating
in the sequence of cellular events leading to malignant tumor development. Future therapies aimed at restoring or
circumventing cilia signaling might therefore aid in current treatment efficacy.
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Primary cilia are small hair-like organelles that generally
extend from the apical plasma membrane and are almost
ubiquitously expressed throughout the human body [1].
Cilia function as sensory organelles in response to extra-
cellular stimuli, such as fluid flow (mechanosensation) in
addition to mitogenic, morphogenic and olfactory fac-
tors. Ciliary signaling is pivotal during development and
organ homeostasis [2]. Dysfunctional cilia underlie the
development of a broad range of diseases, collectively
known as ciliopathies. Hallmark disease syndromes that
find their origin in cilia dysfunction include polycystic
kidney disease (PKD), Bardet-Biedl syndrome (BBS),
Meckel-Gruber syndrome (MKS) and nephronophthisis
(NPHP) [3]. These syndromes have a partially overlap-
ping disease spectrum and interestingly, one of the most
frequently affected tissues is the kidney, which is charac-
terized by a high prevalence of renal cyst formation [3].
The tubules that make up the nephron are highly cilia-
ted and essential for regulating cell proliferation in re-
sponse to fluid flow, as well as maintaining planar
organization of the tissue [4]. Loss of cilia in the renal
tubules has been described to induce a switch from non-
canonical to canonical Wnt signaling that leads to in-
appropriate β-catenin activation, cell proliferation and loss
of planar cell polarity, however there is some controversy
concerning the exact mechanisms involved [5]. In general,
loss of ciliary function marks the initiation of cyst forma-
tion eventually severely impairing renal function.
Kidney cancers can be subcategorized into several histo-
pathological subtypes, of which renal cell carcinoma
(RCC) is the most predominant [6]. Distinct RCC patholo-
gies are clear cell (ccRCC) with an incidence of 75%, papil-
lary (pRCC, 10 to 15%) and chromophobe (chrRCC, 5%)
[7]. Closely resembling the histology of chromophobe
RCC is the subtype renal oncocytoma with a prevalence of
5% [8,9]. The overall majority of kidney cancers is spor-
adic and 4% is attributable to heritable cancer syndromes
[6]. The best-studied familial kidney cancer syndrome is
Von Hippel-Lindau disease (VHL, MIM608537), predis-
posing to ccRCC development as well as extrarenal tumor
development [10]. Interestingly, the VHL gene is also inac-
tivated in up to 87% of sporadic clear cell RCCs [11].
Tuberous sclerosis (TSC) is associated with germline
mutations in the TSC1/Harmatin (MIM605284) and
TSC2/Tuburin (MIM191092) genes [12]. The renal path-
ology of TSC patients is predominantly benign renal
angiomyolipoma (50 to 80%), although a minority deve-
lops ccRCC with an earlier onset of disease compared to
the general population (3%) [13]. Birt-Hogg-Dubé syn-
drome (BHD) is a monogenic disorder caused by muta-
tions in FLCN/Folliculin [14] (MIM607273). Renal tumors
isolated from BHD patients are histologically diverse, pre-
dominantly consisting of chrRCC (34%) and hybridoncocytoma/chromophobe (50%) neoplasms, and less fre-
quently ccRCC (9%) [15]. Interestingly, the gene products
of these heritable kidney cancer loci have all been directly
linked with cilia function. As renal cysts are common fea-
tures in VHL, TSC and BHD syndromes, a common hy-
pothesis is that renal transformation originates from cystic
lesions comprising a pretumorigenic stage in the natural
disease course. In VHL patients, direct evidence of this
transformation has been documented [16]. This is further
supported by the observation that patients with acquired
cystic kidney disease (ACKD) have an increased risk for
RCC with incidences ranging from 2 to 5% [13], and the
development of both cysts and RCC in mouse models for
VHL disease [17], TSC [18] and BHD syndrome [19].
During the cell cycle, both the cilium and the mitotic
spindle lay claim to the centrosome, rendering these pro-
cesses mutually exclusive and cilia must therefore first be
disassembled prior to cell division [20,21]. Collectively,
these data raise the question of whether renal cell carcin-
omas sustain normal ciliary frequencies. One study in a
small cohort of ccRCC indeed establishes some initial sup-
port for this hypothesis [22]. Here we analyze cilia fre-
quency in renal tumor resections by immunohistoche-
mistry for cilia axonemal marker acetylated-α-tubulin. In
order to efficiently and reproducibly analyze a large num-
ber of patients in standardized conditions, we used a tis-
sue microarray (TMA) of RCC biopsies, including eighty-
nine ccRCC, eight pRCC, five chrRCC, two sarcomatoid
renal tumors and six oncocytomas [23]. The TMA addi-
tionally includes tissue originating from the benign renal
parenchyma surrounding the tumor, which we used to
correlate the ciliary frequencies in RCC.
Methods
Patient material and tissue microarray
The tissues analyzed in this study were obtained from
nephrectomy samples collected from patients at the Uni-
versity Medical Center Utrecht (UMCU) and part of the
UMCU biobank. All patient samples conform to the
medical and ethical guidelines applied by the UMCU
and Dutch law. Selected tissues comprise a variety of
RCC histologies; eighty-nine ccRCC, eight pRCC, five
chrRCC, six oncocytomas and two sarcomatoid renal
tumors (Table S1 in Additional file 1). The TMAs were
previously constructed using an arrayer (Beecher Instru-
ments, Sun Prairie, WI, USA) and three cores of 1 mm
in diameter from the cancer tissue, and three cores of 1
mm in diameter from the healthy renal parenchyma tis-
sue taken anywhere between 1 cm and 8 cm from the
edge of the tumor were included. Every composite paraf-
fin block included the same tumor and parenchyma tis-
sue for normalization. All tissues and corresponding
patient information used were well documented and pre-
viously categorized for histological subtype [23].
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TMA sections of 4 μm were processed as previously
described [23]. Following deparaffination and rehydration,
antigen retrieval was achieved by boiling in citrate buffer
for 20 minutes and the sections were allowed to cool to
room temperature over one hour on the bench. Endoge-
nous peroxidase activity was blocked with 3% H2O2 for 15
minutes before blocking with 5% horse serum for one
hour at room temperature. Acetylated-α-tubulin antibody
from Sigma-Aldrich (St. Louis, MO, USA) (clone 6-11B-1
purified from mouse, 1:12,000) and Ki67 antibody from
Dako (Glostrup, Denmark) (1:200) were used for primary
staining overnight at 4°C. Secondary antibody staining was
performed using anti-mouse HRP (1:100) and Power-
Vision (Immunologic, Duiven, The Netherlands) activated
with H2O2 and stained with Novared. Serial sections were
counterstained 15 to 30 seconds with hematoxylin and
developed for 10 minutes in running tap water. To deter-
mine the amount of actively proliferating cells, the per-
centage of Ki67 positive cells were blindly scored by
a pathologist together with an independent researcher
(Table S1 in Additional file 1). The mean score of the
three cores was used.
Immunofluorescence
After deparaffination and rehydration, 4 μm sections were
digested in protease XXIV (Sigma-Aldrich, 0.02 mg/ml in
PBS, pH 7.3, 60 minutes at room temperature) [24]. After
washing and blocking in 1% BSA in PBS, primary anti-
bodies (mouse monoclonal acetylated-α-tubulin, clone 6-
11B-1 (Sigma-Aldrich) 1:12,000, and rabbit polyclonal anti-
pericentrin (Novus Biologicals, Littleton, CO, USA) 1:100)
were incubated for 60 minutes at room temperature. After
repeated washing in PBS, secondary antibodies are incu-
bated for an additional 60 minutes at room temperature:
goat anti-mouse conjugated to Cy5 (Millipore, Bedford,
MA, USA) (1:100) and goat anti-rabbit-Cy3 (Life Tech-
nologies, Carlsbad, CA, USA) (1:100). Sections were
washed again repeatedly, incubated in DAPI (diluted
1:5,000 in PBS) for 15 minutes and after a final round of
washes in PBS, mounted with Fluoromount G. Stained sec-
tions are stored in the dark at 4°C until confocal imaging
with a Zeiss LSM700 63x objective (Carl Zeiss Microscopy,
Jena, Germany). Z-stacks covering 4 μm were taken until
approximately 300 nuclei were scored blindly for cilia.
Cilia counting and automated nuclei counting
Acetylated-α-tubulin-stained TMA sections were scanned
at high resolution and analyzed using Aperio Imagescope
(Aperio, Vista, CA, USA) [25]. Manual cilia counts were
made from scans using a 40X digital zoom. The number
of cilia counted was randomly double-checked by an addi-
tional researcher. Hematoxylin and eosin (H&E)-stained
TMA sections were similarly scanned and individualtissue spots exported using Aperio Imagescope. Using
Photoshop, a color selection range was matched to
hematoxylin (as indicated in Figure S1 in Additional file 2).
This selection was extracted from the original image to re-
move background and converted and inverted to an
8-bit file using ImageJ and built-in macros. Next, a binary
image threshold was set between 10 and 255. The particle
analysis was set for between a 25 and 300 pixel range and
singularity 0 to 1.00 to identify single nuclei. To circum-
vent the problem of aggregated nuclei, a second and third
particle analysis was performed using 300 to 550 and 550
to 5,000 pixel ranges to identify ‘two nuclei’ and ‘>’ re-
spectively. The events identified by the various pixel ana-
lyses were summarized to calculate the total number of
cells, where the event number identified ‘two nuclei’/300
to 550 pixel range was multiplied by two, and the ‘>’/550
to 5,000 pixel range was multiplied by five. The latter was
chosen as, although visual observation shows a large vari-
ation, the number of multicellular clusters was low and
five cells was the average number of cells present in these
clusters. The number of events identified in the 550 to
5,000 pixel range analysis was typically low; ranging from
0 to 50 events, 51 to 100 events were observed in densely
populated cores. Once the number of events obtained in
the 550 to 5,000 pixel range analysis exceeded 100 events,
the sample was excluded as the automated nuclei count
became unreliable. To validate, the automated results
generated were overlaid on the original image for 10 ran-
dom images and an error margin <10% was determined
(Table S2 in Additional file 3).
Statistics
For Figure 1B, we compared the normalized cilia frequen-
cies of randomly chosen tumor tissues. Using a paired
t-test analysis at 95% confidence (Prism5) we determined
P <0.0001 and r = 0.9552 (n = 20). For Figure 2F, cilia fre-
quencies were calculated as a percentage of cilia events
compared to nuclei events. The averaged cilia frequencies
of three core sections we compared between parenchymal
tissue and tumor tissue. Using paired t-test analyses at
95% confidence (Prism5), the cilia frequencies of ccRCC,
oncocytoma and chrRCC populations were determined
at P <0.0001 (n = 89), P = 0.0078 (n = 6) and P = 0.0444
(n = 5) respectively.
Results
Classification of renal tumors
A collection of renal tumor biopsies and tissue of the
tumor parenchyma, recovered 1 cm to 8 cm adjacent to
the tumor lesion, was used to compile a TMA. Sections
were previously well-documented and classified accor-
ding to WHO standards by pathologists [23]. Both the
tumor and parenchymal tissue were represented by three
cores 1 mm in diameter. A total of eighty-nine clear cell
Figure 1 Immunofluorescent analysis of cilia in renal tissues.
(A) Sections (4 μm) of renal parenchymal tissues and tumor tissues
were stained with DAPI, acetylated-α-tubulin (Ac-tub) and
pericentrin (PCNT) to mark cell nuclei and cilia. Presented images are
maximal projections of confocal images of typical parenchymal
tissue and a representative ccRCC. Scale bars 20 μm. (B) Normalized
cilia frequencies of renal tumors, shown are paired quantifications of
n = 20 samples. The plot compares the two cilia quantification
methodologies described; data was obtained by immunofluorescent
(IF) confocal image acquisition or scoring of immunohistochemical
(IHC) stained sections. Statistics were determined by performing a
paired t-test at a 95% confidence interval.
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patients, eight papillary RCC (pRCC), five chromophobe
RCC (chrRCC), six oncocytomas and two sarcomatoid
renal tumors and their corresponding parenchymal tis-
sue were analyzed.
Analysis of total cell numbers in normal and cancer tissue
In order to generate a percentage of ciliation per sample,
the number of cells composing each core section was
determined. For this, we developed a methodology to
automatically count the number of nuclei per core (for
an extended description see the Methods section). In
brief, a colorimetric selection is set to match the nuclear
marker hematoxylin and extracted to deplete background.
Subsequently, images are further processed and analyzed
using ImageJ particle analysis to determine the total nuclei
number per core (Figure S1A, B in Additional file 2).
Overlaying the identified nuclear events from the auto-
mated analysis with the original core for 10 samples ofvarious pathologies indicates there to be an underestima-
tion error that is <10% for ccRCC and chrRCC and onco-
cytoma (Figure S1C in Additional file 2, Table S2 in
Additional file 3). pRCC cell nuclei are often intensely
stained and aggregated, as the automated analysis
exceeded our predetermined parameter threshold (see
Methods) and rendered the automated quantification
unreliable, we excluded these samples for automated
nuclei count. It is important to emphasize that the
acetylated-α-tubulin-stained TMAs that we use to
count cilia frequencies were not suitable for automated
nuclei count as the immunohistochemistry (IHC) inter-
feres with the nuclear hematoxylin signal; we therefore
used corresponding hematoxylin and eosin-stained
TMA sections checked for matching morphology and
cell counts.
Cilia frequency in renal tumor cores
TMA sections were stained by immunofluorescence with
acetylated-α-tubulin and pericentrin, established markers
for the axoneme and base of the cilium, respectively.
This approach allows sensitive high-resolution images of
cilia to be captured and scored using confocal z-stack
imaging (Figure 1A); however, for comparing a large
number of patients systematically in a single experiment,
we found that the imaging time required for each core
(approximately 1 hour per patient) negatively affected
subsequent sample signals through indirect bleaching,
warming and aging. We therefore validated immu-
nofluorescent high-resolution immunostaining in 20
random patients with standard immunochemistry for
acetylated-α-tubulin. Standard IHC for acetylated-α-
tubulin could obtain more data through semi-automatic
processing; however, it was not clear that the lesser sen-
sitivity to signal and 3D processing would produce cil-
iary frequency data comparable to immunofluorescence.
Prior to manually counting cilia, parameters were estab-
lished by which putative cilia were to be included or
excluded: 1) size; the cilium needed to be a thin struc-
ture, intensely stained broad structures were considered
background; 2) elongation; the cilium needed to be a
continuous thin extending structure, square or dot-like
structures were excluded. Because higher cilia counts
overall were observed using the immunofluorescent
stainings, we compared normalized data when the par-
enchymal tissue ciliation frequency was set to 100%. In
this analysis, we observe an extremely strong correlation
(r = 0.9552) between ciliary frequencies in all 20 samples
comparing both techniques (Figure 1B).
We therefore felt confident that an approach involving
IHC was justified and would yield relevant results in a
greater number of patients that we could compare in a
single experiment. Both staining protocols clearly mark
cilia in luminal spaces in the normal tissues present on
Figure 2 Determination of cilia frequency. (A) Acetylated-α-tubulin-stained renal tissue section obtained from the parenchyma of tumor tissue
shows the presence of cilia lining tubular structures. Structures encircled in green are identified as cilia, red encircled structures are considered
aberrant acetylated-α-tubulin staining or lack sufficient clarity. Stromal or supportive tissue cells between tubules typically do not have cilia.
(B) Acetylated-α-tubulin-stained section of tissue obtained from typical and abnormal parenchymal tissue and a typical ccRCC. (C-E) Hematoxylin
and eosin (H&E) and acetylated-α-tubulin stainings of a typical oncocytoma, chromophobe RCC (chrRCC) and sarcomatoid renal tumor. (F) Scatter
plot and median of cilia frequency in parenchymal (P, green) tissues compared to matched RCC subtypes (T, red). Significant populations using
t-test (95% confidence) are indicated with asterisks. All images 1 mm core and outlined magnifications.
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tumor tissue and the parenchyma surrounding the tumor;
three cores per tissue were scored. All cores were manua-
lly counted and the number of cilia per core was norma-
lized to the number of nuclei as determined by the
automated analysis, generating a percentage of ciliation
per core (Table S1 in Additional file 1). The ciliation per-
centage was averaged for all three cores, we excluded
cores that either generated nuclei numbers considered un-
reliable or showed visually aberrant acetylated-α-tubulin
staining. In total, the TMA contained n = 89 sporadic or
VHL-associated ccRCC (Figure 2B), n = 6 oncocytoma(Figure 2C), n = 5 chrRCC (Figure 2D) and n = 2 sarcoma-
toid renal tumor (Figure 2E) samples that were included in
the cilia frequency analysis (Table S1 in Additional file 1).
Sections of pRCC proved unsuitable for automated nuclei
counting and on visual inspection of acetylated-α-tubulin-
stained sections they appeared generally overstained and
were not quantified. Of note, careful visual inspection of
pRCC suggest this subtype to similarly exhibit reduced
cilia numbers, although on occasion tubular structures
can be identified that appear to contain cilia (Figure S2 in
Additional file 4). We next compared the average ciliation
frequencies of parenchymal tissue (P, in green) to their
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(Figure 2E). Overall, ccRCC, oncocytoma, chrRCC and
sarcomatoid renal tumors show a marked reduction in
cilia frequency. A number of parenchymal samples ap-
pear to have cilia frequencies in the same range as tumor
tissue samples, visual examination of these samples indi-
cate that this parenchymal tissue was rather abnormal
and contains either excessive stromal/supportive tissue
or tumor cells (Figure 2B).
Reduced ciliation in RCC subtypes is independent of cell
proliferation
Cilia retraction occurs prior to cell duplication to allow
for centrosome duplication and spindle pole formation,
in early stages of the new cell cycle ciliogenesis is
restored but restricted to cells that exit the cell cycle
[26]. To ensure that the reduced cilia numbers are a
characteristic of oncogenic transformation and exclude
the possibility that this is due to an increase in prolifera-
tion, we performed antibody staining using the widely
accepted proliferation marker Ki67. Three core tumor
cores were blindly scored to determine the percentage of
positively stained cells; results were averaged per sample.
Except for the sarcomatoid tumor showing 23%, nearly
all tumor samples had proliferation indexes, <5% (excep-
tions were a single VHL/ccRCC with 12% and a single
chrRCC with 7.5%), which is too low to solely account
for the observed loss of cilia (Table S1 in Additional file 1).
Discussion
The effect of oncogenic transformation on cilia stability
is tissue-specific and depends on the underlying muta-
tion spectrum. It has been previously shown that cilia
are less stable in early stages of melanoma and pancre-
atic ductal carcinoma development [27,28]. However,
certain tumor types appear to depend on proper cilia
formation, such as hedgehog-dependent basal cell car-
cinomas and medulloblastomas [29,30]. A number of
tumor suppressor genes that have established roles in
renal tumorigenesis, namely VHL, TSC1, TSC2 and
FLCN, also predispose to renal cyst formation, a com-
mon hallmark of ciliopathy syndromes. Indeed, these
proteins have been shown to exert molecular activity to-
wards cilia function. VHL interacts with the essential
cilia microtubule motor complex kinesin-2 [31] and loss
of cilia in mouse tissues is observed upon loss of Vhlh
(the mouse ortholog of VHL) and either Pten [32] or
Gsk3β [33]. We recently presented data concerning the
role of FLCN in cilia formation show transiently reduced
cilia formation in FLCN-depleted renal cells [34,35]. In
contrast, loss of Tsc1 or Tsc2 enhances cilia length in
mouse embryonic fibroblasts (MEFs) [36], and intri-
guingly, clinically there is a relatively low frequency of
renal cyst and RCC formation in TSC patients [12].Based on these observations we posed the question: to
which extent is cilia frequency globally affected in RCC
samples? We analyzed cilia frequency in renal tissue sec-
tions present in triplicate on a TMA of 110 patients, in-
cluding RCC tissue and tissue obtained from the tumor
parenchyma, and observed a severe reduction of cilia
frequency in the various RCC subtypes. Our data sup-
ports, extends and confirms that the low ciliary fre-
quency characteristic of renal cysts remains an evident
characteristic of most renal tumors [22]. Potential effects
on cilia function could not be analyzed in this approach,
hence we cannot exclude whether cilia function in the
normal tissue is also affected. Furthermore, the paren-
chymal tissue is likely also stressed and may very well be
nonrepresentative of normal kidney function. Future
analysis of downstream targets of signaling pathways
common to cilia, such as the GLI3 and TCF/LEF tran-
scription factors downstream of respectively the Shh and
Wnt-pathways, might shed light on impaired cilia func-
tion in pretumorigenic tissue.
The underlying principle of cilia resorption exhibited by
tumor cells and the putative necessity remains a highly
debated topic. One possibility is that the loss of cilia pro-
motes, or at least contributes to, an environment rende-
ring these cells more susceptible to mitogenic cues that
initiate proliferation. The mechanism is much more com-
plex though, as classic ciliopathies (PKD, BBS, MKS,
NPHP) do predispose to renal cysts, yet renal tumors are
only rarely observed [20]. The best characterized functions
of VHL, TSC1, TSC2 and FLCN are also not directly
related to cilia regulation, and RCC formation firstly
depends on deregulated metabolic signaling [37]. The best
characterized function for VHL is inactivation of HIF
transcription factors in normoxic conditions through pro-
teasomal degradation [38]. As a result of altered metabolic
pathways, kidney cancers typically show a Warburg effect;
where the use of glycolysis is promoted over mitochon-
drial oxidative phospholylation. All genetic factors con-
tributing to hereditary kidney cancer (including MET, FH
and SDH) described to date play regulatory roles in meta-
bolic pathways regulated by nutrient-, oxygen-, iron- and
energy-sensing. However, TSC1, TSC2 and FLCN have
established roles in energy- and nutrient-sensing pathways
through AMPK (5’-adenosine monophosphate-activated
kinase) and downstream mTOR [37], and it is becoming
evident that mTOR signaling and LKB1, an upstream
kinase of AMPK, are both directly linked to cilia [39,40].
Combined, RCC seems to be a two-step process in which
both the primary cilium function needs to be impaired as
well as modification of the metabolic pathways and un-
coupling regulation by energy, nutrients, oxygen and iron.
Therapies aimed at restoring, stabilizing or molecularly
circumventing cilia function might therefore be a suitable
addition to current treatment strategies in an endeavor to
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tumorigenic progression from this premalignant state [41].Conclusions
The crucial role of primary cilia in regulating renal
homeostasis and the links to cell proliferation and
polarization are intriguing facets in light of renal cancer
research. In addition, findings that associate renal tumor
suppressor proteins as ciliary functions regulators sug-
gest that renal tumor cells preferentially are nonciliated.
We therefore addressed the status of this organelle in
RCC tissue. In this study, we included material from 110
patients of various RCC subtypes and compared three
cores of RCC tissue to parenchymal renal tissue from
the same patient. A severe reduction of cilia frequency
in the various RCC subtypes is observed, which is inde-
pendent of proliferation. Our results suggest that cilia
loss is a common event in renal tumorigenesis and im-
plies that cilia loss is part of a sequence of events leading
to renal malignant tumor development.Additional files
Additional file 1: Table S1. Sample data of parenchymal and RCC
tissues.
Additional file 2: Figure S1. Automated nuclei count on HE-stained
TMA. (A) Hematoxylin specifically marks cell nuclei, generating a dark-blue/
purple color. In Photoshop, using the color picker, a color selection was
matched to the hematoxylin signal (indicated in white boxes) and
extracted. In ImageJ, the extracted image fragments are converted to 8-bit
and made binary. (B) A total of three particle analyses are run per image,
counting single (green), double (blue) and clustered cells (“>”, white) in the
merged image, inverted separate analyses images shown for clarity.
(C) Overlay of the particle analysis and the original image. Manual validation
of accuracy was analyzed for 10 random samples (see Table S1). For clarity,
the overlay with the original tissue is also shown in black and white; events
not recognized by the automated nuclei count are indicated.
Additional file 3: Table S2. Validation of automated nuclei count.
Randomly selected sections (n = 10) of parenchymal and tumor tissues
were analyzed by overlaying the original image with recovered particle
analysis events. The number of nuclei that are not recognized by the
automated methodology are used to calculate the percentage of error.
The error typically indicates an underrepresentation.
Additional file 4: Figure S2. Papillary RCCs are unsuitable for
quantification. Three representative sections of papillary RCCs stained
with hematoxylin and eosin (H&E) shows strongly stained and densely
distributed nuclei. In accordance with our defined parameters, automated
nuclei determination proved unreliable. Acetylated-α-tubulin staining
shows intense levels in papillary RCC (pRCC) that renders them
inadequate for reliable quantitative scoring. It can be appreciated that
parts of the tissue has maintained some tubular structure and close
observation incidentally shows cilia present (green circles), however our
general impression is that cilia numbers are reduced in pRCC.
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